Medchemexpress LLC 3-[4-[(3S)-4-(4-Br-benzoyl)-3-(4-Cl-phenyl)piperazine-1-carbonyl]-5-methylpyrazol-1-yl]benzonitrile | 2095486-67-0 | 100.0% | 588.88 g/mol | C29H23BrClN5O2 | 50 MG

Supplier:  Medchemexpress LLC HY10151350MG

eIF4A3-IN-1 is a research-grade small-molecule inhibitor of the eukaryotic translation initiation factor eIF4A3, used in biochemical, cellular, and in vivo studies. It displays selective eIF4A3 inhibition with reported antitumor and analgesic activity in preclinical models. The compound is supplied as a high-purity solid or DMSO solution and is commonly formulated in DMSO for in vitro work.

• Selective inhibitor of eIF4A3 with demonstrated cellular activity.
• High purity suitable for analytical and biological assays.
• Available as solid and as 10 mM solution in DMSO for convenient dosing.
• Recommended solvent for in vitro use: DMSO; in vivo example: 10% DMSO in corn oil.
• Stable when stored frozen as powder or in solution under recommended conditions.
• Suitable for biochemical assays, cell-based studies, and in vivo preclinical models.

Catalog No. 50-002-46170